ORTX - Orchard Therapeutics' (ORTX) CEO Bobby Gaspar on Q4 2021 Results - Earnings Call Transcript
Orchard Therapeutics PLC (ORTX) Q4 2021 Earnings Conference Call March 30, 2022 8:00 AM ET Company Participants Bobby Gaspar – Chief Executive Officer and Co-Founder Braden Parker – Chief Commercial Officer Frank Thomas – President and Chief Operating Officer Conference Call Participants Kevin DeGeeter – Oppenheimer Yaron Werber – Cowen Pete Stavropoulos – Cantor Fitzgerald Gena Wang – Barclays Dae Gon Ha – Stifel Tess Romero – JPMorgan David Hoang – SMBC Presentation Bobby Gaspar Hello, and welcome to Orchard Therapeutics Fourth Quarter and Year End 2021 Financial Results and Corporate Update Webcast. I’m CEO and Co-Founder, Bobby Gaspar. Before we get started, I want to remind everyone that this presentation contains forward-looking statements. Please refer to the slide and our latest SEC filings for more information. Three colleagues will be joining me on today’s call; Braden Parker, our Chief Commercial Officer, who many of you know from prior event,
For further details see:
Orchard Therapeutics' (ORTX) CEO Bobby Gaspar on Q4 2021 Results - Earnings Call Transcript